Primary cervical carcinomas show 2 common regions of deletion at 3P, 1 within theFHIT gene: Evaluation of allelic imbalance atFHIT, RB1 andTP53 in relation to survival
Open Access
- 13 September 2000
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 88 (2) , 217-222
- https://doi.org/10.1002/1097-0215(20001015)88:2<217::aid-ijc11>3.0.co;2-i
Abstract
Chromosome arm 3p is re‐arranged in many tumor types, including cervical carcinomas. Putative tumor‐suppressor genes on 3p have been proposed, including the FHIT gene, which maps to chromosome band 3p14.2. We have analyzed 79 primary cervical carcinomas for allelic imbalance (AI) at 17 chromosome 3 loci, including 3 within the FHIT gene. Expression of the FHIT gene was evaluated after immunohistochemistry with an antibody against the pFHIT protein. Previously determined human papillomavirus status, defined after in situ hybridization, showed type 16 or 18 in 56/77 tumors. Tumors were also analyzed for AI at loci within the RB1 (chromosome band 13q14.2) and the TP53 (17p13) genes for AI. AI was found at 1 or more 3p loci in 50/79 tumors, at frequencies ranging from 30% to 52% at the individual loci. Two smallest regions of overlapping deletion (SROs) were found, 1 including parts of the FHIT gene (SRO flanked by D3S1481 and D3S1313) and another more distal SRO between D3S32 and D3S1286. FHIT protein expression was reduced in 57/69 (83%) tumors but not associated with AI at FHIT loci (p = 0.56). AI was found in TP53 and RB1 in 18% and 29% of the samples, respectively. Relapse‐free survival was associated with AI in the TP53 gene in both a univariate (p = 0.0003) and a multivariate (p = 0.004) analysis. This study confirms a high frequency of AI at chromosome arm 3p in primary cervical carcinomas. The AI results and the reduced FHIT protein staining indicate that FHIT alterations are important in cervical carcinogenesis. Int. J. Cancer 88:217–222, 2000.Keywords
This publication has 37 references indexed in Scilit:
- Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus loadBritish Journal of Cancer, 1998
- Loss of heterozygosity in clinical stage IB cervical carcinoma: Relationship with clinical and histopathologic featuresHuman Pathology, 1998
- HPV-associated cervical cancers show frequent allelic loss at 3p14 but no apparent aberration of FHIT mRNAInternational Journal of Cancer, 1998
- Cytogenetics of carcinoma of the cervix uteri: A reviewCancer Genetics and Cytogenetics, 1997
- Fhit, a Putative Tumor Suppressor in Humans, Is a Dinucleoside 5‘,5‘ ‘‘-P1,P3-Triphosphate HydrolaseBiochemistry, 1996
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995
- Human Papillomavirus Infection Is Transient in Young Women: A PopulationBased Cohort StudyThe Journal of Infectious Diseases, 1995
- Genetic alterations of the TP53 gene, p53 protein expression and hpv infection in primary cervical carcinomasThe Journal of Pathology, 1993
- Absence of Mutation in the p53 and the Retinoblastoma Susceptibility Genes in Primary Cervical CarcinomasVirology, 1993
- Regional chromosome localization of human papillomavirus intergration sites near fragile sites, oncogenes, and cancer chromosome breakpointsCancer Genetics and Cytogenetics, 1988